The global healthcare landscape is witnessing a revolutionary shift toward non-invasive diagnostics, with the Cancer Spit Test Devices Market at the forefront of this change. Often referred to as "saliva liquid biopsy," these devices allow for the detection of cancer biomarkers—such as circulating tumor DNA (ctDNA) and specific proteins—through a simple, painless saliva sample. https://www.databridgemarketresearch.com/